Cargando…

Pulmonary complications of immune checkpoint inhibitors in patients with nonsmall cell lung cancer

Immune checkpoint inhibitor-related pneumonitis (ICI-P) during cancer treatment is rarely observed (<5%). ICI-P is more often observed in patients with nonsmall cell lung cancer (NSCLC) than in those with other cancers. Likewise, it is more common in those receiving programmed cell death (PD)-1/P...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cadranel, Jacques, Canellas, Anthony, Matton, Lise, Darrason, Marie, Parrot, Antoine, Naccache, Jean-Marc, Lavolé, Armelle, Ruppert, Anne-Marie, Fallet, Vincent
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Respiratory Society 2019
Materias:	Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9488121/ https://www.ncbi.nlm.nih.gov/pubmed/31597674 http://dx.doi.org/10.1183/16000617.0058-2019

Ejemplares similares

Local ablative therapy in oncogenic-driven oligometastatic non-small cell lung cancer: present and ongoing strategies—a narrative review
por: Fallet, Vincent, et al.
Publicado: (2021)

Brief Report of Anti–Programmed Cell Death Protein-1 in Human Immunodeficiency Virus Setting: Relevant and Breaking Results in First-Line NSCLC Therapy
por: Bertin, Lise, et al.
Publicado: (2021)

Factors associated with early progression of non-small-cell lung cancer treated by epidermal growth factor receptor tyrosine-kinase inhibitors
por: Rozensztajn, Nathalie, et al.
Publicado: (2014)

Augmentation des délais de prise charge du cancer du poumon pendant la pandémie COVID-19 : expérience d’un centre de diagnostic rapide ambulatoire
por: Wang, P., et al.
Publicado: (2022)

Efficacy of next treatment received after nivolumab progression in patients with advanced nonsmall cell lung cancer
por: Costantini, Adrien, et al.
Publicado: (2018)

Spotlight on crizotinib in the first-line treatment of ALK-positive advanced non-small-cell lung cancer: patients selection and perspectives
por: Leprieur, Etienne Giroux, et al.
Publicado: (2016)

Diagnosis and prognosis of acute respiratory distress syndrome related to diffuse pneumonic-type adenocarcinoma: a single-center case series study
por: Decavèle, Maxens, et al.
Publicado: (2022)

An integrated approach to diagnosis and management of severe haemoptysis in patients admitted to the intensive care unit: a case series from a referral centre
por: Fartoukh, Muriel, et al.
Publicado: (2007)

Life-threatening hemoptysis in adults with community-acquired pneumonia due to Panton-Valentine leukocidin-secreting Staphylococcus aureus
por: Boussaud, Véronique, et al.
Publicado: (2003)

Lung cancer is also a hereditary disease
por: Benusiglio, Patrick R., et al.
Publicado: (2021)

Mechanistic and topological explanations in medicine: the case of medical genetics and network medicine
por: Darrason, Marie
Publicado: (2015)

Study protocol: exploring the efficacy of cyclophosphamide added to corticosteroids for treating acute exacerbation of idiopathic pulmonary fibrosis; a randomized double-blind, placebo-controlled, multi-center phase III trial (EXAFIP)
por: Naccache, Jean-Marc, et al.
Publicado: (2019)

Interstitial Lung Disease Associated with Lung Cancer: A Case–Control Study
por: Gibiot, Quentin, et al.
Publicado: (2020)

MET exon 14 mutations as targets in routine molecular analysis of primary sarcomatoid carcinoma of the lung
por: Saffroy, Raphaël, et al.
Publicado: (2017)

Interstitial Lung Disease in Werner Syndrome: A Case Report of a 55-Year-Old Male Patient
por: Goletto, Tiphaine, et al.
Publicado: (2015)

Therapeutic strategies to overcome EGFR mutations as acquired resistance mechanism in ALK-rearranged non-small-cell lung cancer: Case Reports
por: Michaux, Lionel, et al.
Publicado: (2023)

Prognostic factors of toxicity of immune checkpoint inhibitors in nonsmall cell lung cancer and small cell lung cancer patients: The ToxImmune study
por: Difoum, Francoise, et al.
Publicado: (2022)

Pulmonary Complications Secondary to Immune Checkpoint Inhibitors
por: Albitar, Hasan Ahmad Hasan, et al.
Publicado: (2020)

Rare and frequent postoperative complications after combined pneumonectomy for nonsmall-cell lung cancer
por: Lyas, N, et al.
Publicado: (2013)

Randomised trial of first-line bronchial artery embolisation for non-severe haemoptysis of mild abundance
por: Fartoukh, Muriel, et al.
Publicado: (2021)

Correlation between the Immune Checkpoint Inhibitors Prognostic Index and Outcomes in Nonsmall Cell Lung Cancer: A Multicentre Analysis
por: Zhou, Ying, et al.
Publicado: (2022)

First report of a very rare complication in a case of nonsmall cell lung carcinoma
por: Moreira, Inês, et al.
Publicado: (2021)

A Case of Pulmonary Adenocarcinoma Presenting with Diffuse Cystic Lesions
por: Adrian, Benjamin, et al.
Publicado: (2021)

UKLS trial: looking beyond negative results
por: Darrason, Marie, et al.
Publicado: (2021)

Pyogenic lung abscess in an infectious disease unit: a 20-year retrospective study
por: Maitre, Thomas, et al.
Publicado: (2021)

Rational application of the first‐line chemotherapy and immune checkpoint inhibitors in advanced nonsmall cell lung cancer: A meta‐analysis
por: Cao, Rui, et al.
Publicado: (2019)

Anti-PD-1 immune-related adverse events are associated with high therapeutic antibody fixation on T cells
por: Gazzano, Marianne, et al.
Publicado: (2022)

Personalised medicine for nonsmall cell lung cancer
por: Mascaux, Céline, et al.
Publicado: (2017)

Modern therapies of nonsmall cell lung cancer
por: Jachowski, Andrzej, et al.
Publicado: (2023)

Pro-tumoural CXCL10/CXCR3-A autocrine loop in invasive mucinous lung adenocarcinoma
por: Duruisseaux, Michaël, et al.
Publicado: (2017)

TP53 Mutations in Nonsmall Cell Lung Cancer
por: Mogi, Akira, et al.
Publicado: (2011)

Signatures of Drug Sensitivity in Nonsmall Cell Lung Cancer
por: Gong, Hua C., et al.
Publicado: (2011)

The Role of Proteasome Inhibition in Nonsmall Cell Lung Cancer
por: Escobar, Mauricio, et al.
Publicado: (2011)

Gemcitabine for the treatment of advanced nonsmall cell lung cancer
por: Toschi, Luca, et al.
Publicado: (2009)

Thyroid Metastasis from Nonsmall Cell Lung Cancer
por: Namad, Tariq, et al.
Publicado: (2013)

An IMRT/VMAT Technique for Nonsmall Cell Lung Cancer
por: Zhao, Nan, et al.
Publicado: (2015)

Bronchoscopic treatment of inoperable nonsmall cell lung cancer
por: Kniese, Christopher M., et al.
Publicado: (2020)

The Frequency of Epidermal Growth Factor Receptor Mutation of Nonsmall Cell Lung Cancer according to the Underlying Pulmonary Diseases
por: Usui, Kazuhiro, et al.
Publicado: (2011)

Thrombotic Complications Associated with Immune Checkpoint Inhibitors
por: Wang, Tzu-Fei, et al.
Publicado: (2021)

Exposure–Response Analysis of Osimertinib in Patients with Advanced Non-Small-Cell Lung Cancer
por: Rodier, Thomas, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_9lp470u4fc29lc7qqado3h5s4a